Longitude Capital, an investment firm focused on venture growth investments in biotechnology and medical technology, closed its third fund, at $525m in partner commitments.
{iframe}http://www.finsmes.com/2016/06/biotech-medtech-venture-capital-firm-longitude-capital-closes-fund-at-525m.html{/iframe}